Ncardia

A sheet of paper reading venture capital

CRO

Ncardia snags $60M to boost production of pluripotent stem cells

With $60 million in new funding, Ncardia will be able to determine sooner in the development stage if a drug is safe and effective.

Kyle LaHucik Nov 16, 2021 7:40am

cell line

Newly formed Ncardia inks iPSC licensing deal with Evotec

Dec 6, 2017 8:00am